Profound Medical PROF Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Capital Equipment | $8.41M+32.1% | $6.37M+52.3% | $4.18M+33.3% | $3.14M-3.8% | $3.26M+33.6% | |
| Recurring Non Capital | $10.4M+6.9% | $9.73M-3.8% | $10.12M+16.2% | $8.7M+1.2% | $8.6M+4.4% | |
| Revenue by Geography | ||||||
| CA | $5.8M+88.3% | $3.08M+39.4% | $2.21M-8.3% | $2.41M-24.4% | $3.19M+30.7% | |
| DE | $697K-9.8% | $773K+12.7% | $686K-16.3% | $820K-12.8% | $940K+5.5% | |
| US | $12.32M+0.6% | $12.25M+7.4% | $11.4M+32.4% | $8.61M+11.3% | $7.74M+5.2% | |
| Total Assets by Geography | ||||||
| CA | $189.28M+6.5% | $177.74M+2.5% | $173.43M— | —— | —— | |
| CN | $405K-1.7% | $412K+12.3% | $367K— | —— | —— | |
| DE | $5.24M-11.2% | $5.9M-6.6% | $6.32M— | —— | —— | |
| FI | $13.1M+4.7% | $12.51M-1.0% | $12.64M— | —— | —— | |
| US | $34.88M+3.3% | $33.75M+11.3% | $30.31M— | —— | —— | |
| PP&E (Net) by Geography | ||||||
| CA | $191K-21.4% | $243K-17.6% | $295K— | —— | —— | |
| US | $1.47M+21.7% | $1.2M+14.1% | $1.06M— | —— | —— | |
| Depreciation by Geography | ||||||
| CA | $53K+3.9% | $51K-8.1% | $55.5K-0.9% | $56K-10.4% | $62.5K-5.3% | |
| US | $285K-11.5% | $322K-25.5% | $432.25K-16.1% | $515.5K-11.7% | $583.75K-8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Profound Medical break its business down?
- Profound Medical (PROF) reports revenue by product across 2 parts — Capital Equipment and Recurring Non Capital. Each is extracted from the segment footnotes and tracked over time.
- Where does Profound Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Profound Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
